Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
This study is currently recruiting participants.
Verified March 2013
by New York University School of Medicine
Study NCT01105702 Information provided by New York University School of Medicine
First Received on April 12, 2010. Last Updated on March 6, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Brain Cancer
Additional conditions recognized in this trial
Brain Neoplasms
Glioma
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Nervous System Neoplasms
Neuroectodermal Tumors
Additional drug interventions recognized in this trial
Bevacizumab
Dacarbazine
Lithium
Lithium Carbonate
Temozolomide
More general drug interventions related to this trial
Alkylating Agents
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antidepressive Agents
Antimanic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
New York University School of Medicine
Genentech
Ohio State University
Atlantic Health System
Back to top of Main Content
